UBS Maintains Neutral on Docusign, Raises Price Target to $70
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and raises the price target from $54 to $70.
UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and raises the price target from $54 to $70.